Recent developments in the design of bioreductive drugs.
Denny
W A
WA
Cancer Research Laboratory, University of Auckland School of Medicine, New Zealand.
Wilson
W R
WR
Hay
M P
MP
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000493:pharmacokinetics / Q000494:pharmacology*; D001711:Biotransformation; D015195:Drug Design; D006801:Humans; D010084:Oxidation-Reduction; D011355:Prodrugs / Q000378:metabolism; D059005:Topoisomerase II Inhibitors
D000970:Antineoplastic Agents; D011355:Prodrugs; D059005:Topoisomerase II Inhibitors